Deaths from opioid-related overdoses continue to grow in the US, but public health events of recent times mean that attention has been focused elsewhere.
On the latest instalment of the pharmaphorum podcast, editor in chief Jonah Comstock hosts Tony Mack, CEO at Virpax Pharmaceuticals, in the virtual studio.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh